Why Annexon Inc. (ANNX) Went Down On Thursday? - Yahoo Finance
4 weeks ago • Google News
Annexon Inc (ANNX)
US$ 1.976.2%
Price Chart
Key Statistics
Market Cap
$ 216.14M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.58M
52W High
$ 7.85
52W Low
$ 1.28
Dividend Yield
0.00%
Beta
1.24
Technicals
50-Day MA
2.1536
200-Day MA
4.7722
52 Week High
7.85
52 Week Low
1.285
About ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
Employees
100
Headquarters
Brisbane, CA
CEO
Mr. Douglas E. Love Esq., J.D.
Latest News
Annexon Strengthens Team with Strategic Equity Package: Inside the $1.54 Share Grant - Stock Titan
3 weeks ago • Google News
$ANNX stock is up 13% today. Here's what we see in our data. - Nasdaq
2025-03-17 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg